Citation: Dw. Jones et al., AN AUTOMATED CHROMOGENIC PEPTIDE SUBSTRATE ASSAY FOR COAGULATION-FACTOR-XII, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 183-187
Citation: Mj. Gallimore et al., FACTOR-XII DETERMINATIONS IN THE PRESENCE AND ABSENCE OF PHOSPHOLIPIDANTIBODIES, Thrombosis and haemostasis, 79(1), 1998, pp. 87-90
Citation: Mj. Gallimore et al., THE INCIDENCE OF PSEUDO FXII DEFICIENCY IN LUPUS ANTICOAGULANT POSITIVE PATIENTS, Thrombosis and haemostasis, 1997, pp. 2187-2187
Citation: Hp. Wendel et al., INFLUENCE OF HEPARIN, HEPARIN PLUS APROTININ AND HIRUDIN ON CONTACT ACTIVATION IN A CARDIOPULMONARY BYPASS MODEL, Immunopharmacology, 32(1-3), 1996, pp. 57-61
Citation: Hp. Wendel et al., HEPARIN-COATED DEVICES AND HIGH-DOSE APROTININ OPTIMALLY INHIBIT CONTACT SYSTEM ACTIVATION IN AN IN-VITRO CARDIOPULMONARY BYPASS MODEL, Immunopharmacology, 32(1-3), 1996, pp. 128-130
Authors:
JONES DW
GALLIMORE MJ
WINTER M
COHEN H
MACKIE I
MACHIN S
Citation: Dw. Jones et al., HETEROZYGOUS FACTOR-XII DEFICIENCY WITHIN A GROUP OF BLOOD-DONORS IN KENT, British Journal of Haematology, 93, 1996, pp. 127-127
Citation: Dw. Jones et al., DISCREPANCY BETWEEN CLOTTING, CHROMOGENIC SUBSTRATE AND IMMUNOLOGICALASSAYS FOR FACTOR-XII IN LUPUS ANTICOAGULANT POSITIVE PATIENTS, British Journal of Haematology, 93, 1996, pp. 342-342
Authors:
HAY CRM
MCKERNAN AM
MCEVOY P
JONES DW
GALLIMORE MJ
Citation: Crm. Hay et al., LYMPHOCYTE DYSFUNCTION RELATED TO AMIDOLYTIC ACTIVITY OF FACTOR-VIII CONCENTRATES, Thrombosis and haemostasis, 73(6), 1995, pp. 1017-1017
Authors:
WENDEL HP
HELLER W
SCHULZE HJ
GALLIMORE MJ
Citation: Hp. Wendel et al., APROTININ ADDS BENEFICIAL-EFFECTS TO HEPARIN-COATED DEVICES REGARDS BLOOD-CELLS AND CONTACT SYSTEM ACTIVATION IN AN IN-VITRO CARDIOPULMONARY BYPASS MODEL, Thrombosis and haemostasis, 73(6), 1995, pp. 1346-1346
Citation: Dw. Jones et al., RAISED ELASTASE ALPHA-1-PROTEINASE INHIBITOR COMPLEX LEVELS IN PATIENTS WITH HIV-INFECTION, Thrombosis and haemostasis, 73(6), 1995, pp. 1393-1393
Citation: Dw. Jones et al., EVIDENCE FOR CONTACT SYSTEM ACTIVATION IN PATIENTS INFECTED WITH HIV, Thrombosis and haemostasis, 73(6), 1995, pp. 1410-1410
Citation: Hp. Wendel et al., THE EFFECTS OF APROTININ ON CHROMOGENIC PEPTIDE SUBSTRATE AND OTHER ASSAYS FOR COMPONENTS OF THE COAGULATION, FIBRINOLYSIS AND PLASMA KALLIKREIN SYSTEMS, Fibrinolysis, 8(5), 1994, pp. 304-308
Authors:
WENDEL HP
HELLER W
GALLIMORE MJ
BANTEL H
MULLERBEISSENHIRTZ H
HOFFMEISTER HE
Citation: Hp. Wendel et al., INFLUENCE OF APROTININ ON DIFFERENT ACTIVATORS OF INTRINSIC COAGULATION PATHWAY IN THE PRESENCE OF ANTICOAGULANTS, Thrombosis and haemostasis, 69(6), 1993, pp. 626-626
Authors:
HELLER W
GALLIMORE MJ
WENDEL HP
HOFFMEISTER HE
Citation: W. Heller et al., INFLUENCE OF HEPARIN, HEPARIN PLUS APROTININ AND HIRUDIN ON CONTACT ACTIVATION IN A CARDIOPULMONARY BYPASS MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 862-862
Citation: Hp. Wendel et al., APROTININ AND ITS EFFECTS ON CHROMOGENIC SUBSTRATE ASSAYS FOR SOME COMPONENTS OF THE PLASMA DEFENSE SYSTEMS, Thrombosis and haemostasis, 69(6), 1993, pp. 1270-1270